No Influence of Exogenous Hyaluronan on the Behavior of Human Cancer Cells or Endothelial Cell Capillary Formation

Hyaluronan (HA), a type of glycosaminoglycan used to construct the extracellular matrix, is involved in the proliferation and motility of cells, including cancer cells. The aim of this study was to determine whether exogenous HA has an influence on cancer in vitro and in vivo. High‐molecular‐weight...

Full description

Saved in:
Bibliographic Details
Published in:Journal of food science Vol. 79; no. 7; pp. T1469 - T1475
Main Authors: Seino, Satoshi, Takeshita, Fumitaka, Asari, Akira, Masuda, Yasunobu, Kunou, Masaaki, Ochiya, Takahiro
Format: Journal Article
Language:English
Published: United States The Institute 01-07-2014
Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyaluronan (HA), a type of glycosaminoglycan used to construct the extracellular matrix, is involved in the proliferation and motility of cells, including cancer cells. The aim of this study was to determine whether exogenous HA has an influence on cancer in vitro and in vivo. High‐molecular‐weight HA (900 kDa) and low‐molecular‐weight HA (10 kDa) were added to several types of cancer cell lines in vitro, and proliferation and invasion were assessed. The effect of HA on capillary formation by human umbilical vein endothelial cells was also analyzed. The results showed that both types of HA had no apparent effect on cellular proliferation, invasion, or capillary formation. In an animal study, the 2 types of HA were orally administered to tumor‐bearing mice at a dosage of 200 mg/kg/d for 4 wk. Analysis using an in vivo imaging system revealed that tumor proliferation and metastasis were not greatly altered by HA administration. Furthermore, CD31 immunohistochemical staining revealed no obvious change in tumor microvessels. Taken together, these results demonstrate that exogenously administered HA has little effect on cancer. This study may support the safety of various forms of HA administration, including oral intake.
Bibliography:http://dx.doi.org/10.1111/1750-3841.12500
istex:9471276594B2B889DBC1534F527166D1507AF2B1
ArticleID:JFDS12500
ark:/67375/WNG-DGF67KFV-9
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0022-1147
1750-3841
DOI:10.1111/1750-3841.12500